Open MR-guided high-dose-rate (HDR) prostate brachytherapy: Feasibility and initial experiences open MR-guided high-dose-rate (HDR) prostate brachytherapy

Pathology and Oncology Research

Volumn 17, Issue 2, 2011, Pages 315-324

  Lakosi, Ferenc ^a   Antal, Gergely ^a   Vandulek, Csaba ^a   Kovacs, Arpad ^a   Toller, Gabor L ^a   Rakasz, Istvan ^b   Bajzik, Gabor ^a   Hadjiev, Janaki ^a   Bogner, Peter ^a   Repa, Imre ^a  

^a SZENT ISTVÁN UNIVERSITY   (Hungary)

^b Kaposi Mor Teaching Hospital   (Hungary)

Author keywords

Brachytherapy; HDR; Image guidance; Open MRI; Prostate cancer

Indexed keywords

CIPROFLOXACIN; IOHEXOL; TAMSULOSIN;

ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER HORMONE THERAPY; CANCER PATIENT; CATHETERIZATION; CLINICAL ARTICLE; DOSIMETRY; DYSURIA; FEASIBILITY STUDY; FOLLOW UP; HEMATOMA; HEMATURIA; HIGH DOSE RATE PROSTATE BRACHYTHERAPY; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MALE; NOCTURIA; NUCLEAR MAGNETIC RESONANCE IMAGING; PROCESS OPTIMIZATION; PROSTATE CANCER; RADIATION DOSE; TREATMENT OUTCOME; TREATMENT PLANNING;

AGED; BRACHYTHERAPY; FEASIBILITY STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM STAGING; PILOT PROJECTS; PROSTATIC NEOPLASMS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, COMPUTER-ASSISTED;

EID: 80051669771     PISSN: 12194956     EISSN: 15322807     Source Type: Journal    
DOI: 10.1007/s12253-010-9319-x     Document Type: Article

References (35)

1. Kásler M, Sz O (2008) European and Hungarian national tasks in oncology. Magy Onkol 52:21-33
2. Jereczek-Fossa BA, Orecchia R (2007) Evidence-based radiation oncology: definitive, adjuvant and salvage radiotherapy for nonmetastatic prostate cancer. Radiother Oncol 84:197-215 (Pubitemid 47299139)
3. Morton G (2005) The emerging role of high-dose-rate brachytherapy for prostate cancer. Clin Oncol 17:219-227 (Pubitemid 40716444)
4. Hoskin PJ, Motohashi K, Bownes P et al (2007) High dose rate brachytherapy in combination with external beam radiotherapy in the radical treatment of prostate cancer: initial results of a randomised phase three trial. Radiother Oncol 84:114-120 (Pubitemid 47284526)
5. Guix B, Bartina JM, Henriquez I et al (2007) Dose escalation by combined treatment 3-D conformal radiotherapy plus HDR brachytherapy as treatment for intermediate-or-high-risk cancer: early toxicity and biochemical outcome of a prospective randomized trial. [Abstract] Radiother Oncol 83(suppl 1):82a
6. Presti JC Jr (2000) Prostate cancer: assessment of risk using digital rectal examination, tumor grade, prostate-specific antigen, and systematic biopsy. Radiol Clin North Am 38:49-58
7. Aigner F, Mitterberger M, Rehder P et al (2010) Status of transrectal ultrasound imaging of the prostate. J Endourol 24:685-691
8. Futterer J (2007) MR imaging in the local staging of prostate cancer. Eur J Radiol 63:328-334 (Pubitemid 47321041)
9. Morgan VA, Kyriazi S, Ashley SE et al (2007) Evaluation of the potential of diffusion-weighted imaging in prostate cancer detection. Acta Radiol 48:695-703 (Pubitemid 47147765)
10. Kim Y, Hsu IC, Lessard E et al (2008) Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiother Oncol 88:148-155
11. Van Lin EN, Futterer JJ, Heymink SW et al (2006) IMRT boost dose planning on dominant intraprostatic lesions: gold markerbased three-dimensional fusion of CT with dynamic contrastenhanced and 1H-spectroscopic MRI. Int J Radiat Oncol Biol Phys 65:291-303
12. Tempany C, Straus S, Hata N et al (2008) MR-guided prostate interventions. J Magn Reson Imaging 27:356-367 (Pubitemid 351214042)
13. Cormack RA, Kooy H, Tempany CM et al (2000) A clinical method for real-time dosimetric guidance of transperineal 125I prostate implants using interventional magnetic resonance imaging. Int J Radiat Oncol Biol Phys 46:207-214 (Pubitemid 30021501)
14. Blumenfeld P, Hata N, DiMaio S et al (2007) Transperineal prostate biopsy under magnetic resonance image guidance: a needle placement accuracy study. J Magn Reson Imaging 26:688-694 (Pubitemid 350194593)
15. Ares C, Popowski Y, Pampallona S et al (2009) Hypofractionated boost with high-dose-rate brachytherapy and open magnetic resonance imaging-guided implants for locally aggressive prostate cancer: a sequential dose-escalation pilot study. Int J Radiat Oncol Biol Phys 75:656-663
16. Menard C, Susil RC, Choyke P et al (2004) MRI-guided HDR prostate brachytherapy in standard 1.5T scanner. Int J Radiat Oncol Biol Phys 59:1414-1423 (Pubitemid 38954063)
17. Susil RC, Camphausen K, Choyke P et al (2004) System for prostate brachytherapy and biopsy in a standard 1.5T MRI scanner. Magn Reson Med 52:683-687 (Pubitemid 39108985)
18. Fischer GS, DiMaio SP, Iordachita II et al (2007) Robotic assistant for transperineal prostate interventions in 3T closed MRI. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 10:425-433
19. Muntener M, Patriciu A, Petrisor D et al (2008) Transperineal prostate intervention: robot for fully automated MR imaging-system description and proof of principle in a canine model. Radiology 247:543-549
20. Hadjiev J, Antal G, Antalffy Z et al (2004) A novel technique with a flexible applicator for MRI-based brachytherapy of cervical cancer. Eur J Gynaecol Oncol 25:347-350 (Pubitemid 38585621)
21. Lakosi F, Antal G, Vandulek C et al (2009) Technical feasibility of transperineal MR-guided prostate interventions in a low-field open MRI unit: canine study. Pathol Oncol Res 15:315-322
22. National Comprehensive Cancer Network: National practice guidelines in oncology-prostate cancer, Version 2, 2008 (monograph online). http://www.nccn.org/professionals/physician-gls/PDF/prostate.pdf
23. Kovács G, Pötter R, Loch T, Hammer J et al (2005) GEC/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer. Radiother Oncol 74:137-148 (Pubitemid 40331870)
24. Baltas D, Kolotas C, Geramani K et al (1998) A conformal index (COIN) to evaluate implant quality and dose specification in brachytherapy. Int J Radiat Oncol Biol Phys 40:515-524 (Pubitemid 28114401)
25. Major T, Polgar C, Somogyi A et al (2000) Evaluation of the dose uniformity for double-plane high dose rate interstitial breast implants with the use of dose reference points and dose nonuniformity ratio. Radiother Oncol 54:213-220 (Pubitemid 30157831)
26. Wu A, Ulin K, Sternick ES (1988) A dose homogeneity index for evaluating 192Ir interstitial breast implants. Med Phys 15:104-107 (Pubitemid 18070717)
27. Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341-1346
28. Zangos S, Eichler K, Engelmann K et al (2005) MR-guided transgluteal biopsies with an open low-field system in patients with clinically suspected prostate cancer: technique and preliminary results. Eur Radiol 15:174-182 (Pubitemid 40109788)
29. Potter R, Kirisits C, Fidarova EF et al (2008) Present status and future of high-precision image guided adaptive brachytherapy for cervix carcinoma. Acta Oncol 47:1325-1336
30. Citrin D, Ning H, Guion P et al (2005) Inverse treatment planning based on MRI for HDR prostate brachytherapy. Int J Radiat Oncol Biol Phys 61:1267-1275 (Pubitemid 40340923)
31. Morton GC, Sankreacha R, Halina P et al (2008) A comparison of anatomy-based inverse planning with simulated annealing and graphical optimization for high-dose-rate prostate brachytherapy. Brachytherapy 7:12-16 (Pubitemid 351274072)
32. Jacob D, Raben A, Sarkar A et al (2008) Anatomy-based inverse planning simulated annealing optimization in high-dose-rate prostate brachytherapy: significant dosimetric advantage over other optimization techniques. Int J Radiat Oncol Biol Phys 72:820-827
33. Akimoto T, Katoh H, Kitamoto Y et al (2006) Anatomy-based inverse optimization in high-dose-rate brachytherapy combined with hypofractionated external beam radiotherapy for localized prostate cancer: comparison of incidence of acute genitourinary toxicity between anatomy-based inverse optimization and geometric optimization. Int J Radiat Oncol Biol Phys 64:1360-1366
34. Fröhlich G, Agoston P, Lövey J et al (2007) Dosimetric evaluation of interstitial high-dose-rate implants for localised prostate cancer. Magy Onkol 51:31-38
35. Antal G, Lakosi F, Vandulek CS et al (2009) MR modelling of the rectal dosimeter probe during MR-guided high-dose-rate (HDR) prostate brachytherapy: feasibility and initial experiences. [Abstract] Radiother Oncol 91(1):38